Custom exome panel revealed new mutations in MAPK14 and novel mutation in RUNX2 gene in patients with PCOS
Abstract Polycystic ovary syndrome (PCOS) is the most common endocrinopathy and is both phenotypically and genotypically heterogeneous. A large number of genetic variants have been found in different genes, so far. Based on the literature, we identified 7 genes and aimed to find new causative varian...
Saved in:
Main Authors: | Yunus Arikan, Taylan Onat |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-01-01
|
Series: | Scientific Reports |
Subjects: | |
Online Access: | https://doi.org/10.1038/s41598-024-81969-9 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
RUNX1 promotes proliferation of cervical cancer through TGFB2-MAPK pathway
by: Yongqin Jia, et al.
Published: (2025-01-01) -
The Use of Yoga in the Treatment of PCOS
by: Agnieszka Przesor Przezor, et al.
Published: (2025-01-01) -
RUNX2 enhances bladder cancer progression by promoting glutamine metabolism
by: Zhigang Huang, et al.
Published: (2025-02-01) -
Whole exome sequencing identifies ABHD14A and MRNIP as novel candidate genes for developmental language disorder
by: Amal Bouzid, et al.
Published: (2025-01-01) -
Somatic Mutations from Whole Exome Sequencing Analysis of the Patients with Biliary Tract Cancer
by: Kyong-Ah Yoon, et al.
Published: (2018-12-01)